まとめ
抗不律薬であるトカインイドは,治療用濃度で患者に軽微な電気生理学的変化を示した. これらの発見は,トカイニドが心臓に同様の効果を持つことを示唆しています.
科学分野:
- 心臓病学 心臓病学
- 臨床電気生理学 臨床電気生理学
- 薬理学 薬理学とは
背景:
- トカインイドは,クラスIBの抗リズム薬です.
- 治療用濃度での電気生理学的効果については,さらなる解明が必要である.
研究 の 目的:
- 患者におけるトカインイドの電気生理学的性質を評価する.
- トコアニドの効果とリドカインの効果を比較する.
主な方法:
- 電気生理学的研究は,11人の患者で実施された.
- トカインイドの静脈内注入を15分間継続する.
- 測定には,様々な心臓のインターバルとシヌスとペースのリズムの下の耐火期が含まれていました.
主要な成果:
- プラズマトカインイドのピーク濃度は平均11.0μg/mlであった.
- AH,HV,QRS,QTc,およびRRの間隔の軽微な,しばしば統計的に無意味な変化.
- 15分後にRR区間が大幅に短縮され,AH区間がわずかに増加しました.
- ペースリズムにおけるQTcの有意な低下.
- 平均動脈圧の漸進的な上昇.
- 心房,A-V節,右心室の効果的耐火期が低下した.
- シヌス節の回復時間やウェンケバッハ周期の長さに重大な変化はありません.
結論:
- トカインイドは,ほとんどの患者でよく耐えました.
- 電気生理学的効果は,治療用プラズマ濃度では一般的に軽度であった.
- 結果は,トカインイドとリドカインの伝導システム効果の間の質的類似性を示唆しています.
関連する概念動画
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:30Cardiac Action Potential
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials